Effect of flaxseed intervention on inflammatory marker C-reactive protein: A systematic review and meta-analysis of randomized controlled trials

Nutrients

Volumn 8, Issue 3, 2016, Pages

  Ren, Guan Yu ^a,b   Chen, Chun Yang ^a,b   Chen, Guo Chong ^a   Chen, Wei Guo ^b   Pan, An ^c   Pan, Chen Wei ^a   Zhang, Yong Hong ^a   Qin, Li Qiang ^a   Chen, Li Hua ^a  

^a MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

C reactive protein; Flaxseed; Meta analysis; Randomized controlled trials

Indexed keywords

C REACTIVE PROTEIN; LIGNAN; LINOLENIC ACID; LINSEED OIL; SAFFLOWER OIL; SOYBEAN OIL; SUNFLOWER OIL; AUTACOID; BIOLOGICAL MARKER;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; BODY MASS; CASSAVA FLOUR; HUMAN; INFLAMMATION; LINSEED; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PUBLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; WHEAT BRAN; WHEAT GERM; ADULT; ADVERSE EFFECTS; BLOOD; COMPLICATION; DIET; DIET THERAPY; FEMALE; FLAX; MALE; MIDDLE AGED; OBESITY; PLANT SEED; RISK FACTOR; TREATMENT OUTCOME;

ADULT; BIOMARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; DIET; FEMALE; FLAX; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; LIGNANS; LINSEED OIL; MALE; MIDDLE AGED; OBESITY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; SEEDS; TREATMENT OUTCOME;

EID: 84960120909     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu8030136     Document Type: Article

References (61)

1. Kovacic, J.C.; Castellano, J.M.; Fuster, V. Cardiovascular defense challenges at the basic, clinical, and population levels. Ann. N. Y. Acad. Sci. 2012, 1254, 1-6.
2. Esser, N.; Paquot, N.; Scheen, A.J. Anti-inflammatory agents to treat or prevent type 2 diabetes, metabolic syndrome and cardiovascular disease. Expert Opin. Investig. Drugs 2015, 24, 283-307.
3. Kaptoge, S.; Di Angelantonio, E.; Lowe, G.; Pepys, M.B.; Thompson, S.G.; Collins, R.; Danesh, J. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: An individual participant meta-analysis. Lancet 2010, 375, 132-140.
4. Kaptoge, S.; Seshasai, S.R.; Gao, P.; Freitag, D.F.; Butterworth, A.S.; Borglykke, A.; Di Angelantonio, E.; Gudnason, V.; Rumley, A.; Lowe, G.D. et al. Inflammatory cytokines and risk of coronary heart disease: New prospective study and updated meta-analysis. Eur. Heart J. 2014, 35, 578-589.
5. Tanaka, S.; Yoshimura, Y.; Kamada, C.; Tanaka, S.; Horikawa, C.; Okumura, R.; Ito, H.; Ohashi, Y.; Akanuma, Y.; Yamada, N. et al. Intakes of dietary fiber, vegetables, and fruits and incidence of cardiovascular disease in japanese patients with type 2 diabetes. Diabetes Care 2013, 36, 3916-3922.
6. Kris-Etherton, P.M.; Harris, W.S.; Appel, L.J. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002, 106, 2747-2757.
7. Pan, A.; Yu, D.; Demark-Wahnefried, W.; Franco, O.H.; Lin, X. Meta-analysis of the effects of flaxseed interventions on blood lipids. Am. J. Clin. Nutr. 2009, 90, 288-297.
8. Paoletti, R.; Gotto, A.M., Jr.; Hajjar, D.P. Inflammation in atherosclerosis and implications for therapy. Circulation 2004, 109, Iii20-Iii26.
9. Muir, A.D. Flax lignans-Analytical methods and how they influence our lunderstanding of biological activity. J. AOAC Int. 2006, 89, 1147-1157.
10. Hall, C., 3rd; Tulbek, M.C.; Xu, Y. Flaxseed. Adv. Food Nutr. Res. 2006, 51, 1-97.
11. Bloedon, L.T.; Balikai, S.; Chittams, J.; Cunnane, S.C.; Berlin, J.A.; Rader, D.J.; Szapary, P.O. Flaxseed and cardiovascular risk factors: Results from a double blind, randomized, controlled clinical trial. J. Am. Coll. Nutr. 2008, 27, 65-74.
12. Jangale, N.M.; Devarshi, P.P.; Dubal, A.A.; Ghule, A.E.; Koppikar, S.J.; Bodhankar, S.L.; Chougale, A.D.; Kulkarni, M.J.; Harsulkar, A.M. Dietary flaxseed oil and fish oil modulates expression of antioxidant and inflammatory genes with alleviation of protein glycation status and inflammation in liver of streptozotocin-nicotinamide induced diabetic rats. Food Chem. 2013, 141, 187-195.
13. Xu, J.; Yang, W.; Deng, Q.; Huang, Q.; Yang, J.; Huang, F. Flaxseed oil and alpha-lipoic acid combination reduces atherosclerosis risk factors in rats fed a high-fat diet. Lipids Health Dis. 2012, 11, 148.
14. Nounou, H.A.; Deif, M.M.; Shalaby, M.A. Effect of flaxseed supplementation and exercise training on lipid profile, oxidative stress and inflammation in rats with myocardial ischemia. Lipids Health Dis. 2012, 11, 129.
15. Barre, D.E.; Mizier-Barre, K.A.; Stelmach, E.; Hobson, J.; Griscti, O.; Rudiuk, A.; Muthuthevar, D. Flaxseed lignan complex administration in older human type 2 diabetics manages central obesity and prothrombosis-an invitation to further investigation into polypharmacy reduction. J. Nutr. Metab. 2012, 2012, 585170.
16. Demark-Wahnefried, W.; Polascik, T.J.; George, S.L.; Switzer, B.R.; Madden, J.F.; Ruffin, M.T.; Snyder, D.C.; Owzar, K.; Hars, V.; Albala, D.M. et al. Flaxseed supplementation (not dietary fat restriction) reduces prostate cancer proliferation rates in men presurgery. Cancer Epidemiol. Biomark. Prev. 2008, 17, 3577-3587.
17. Dodin, S.; Cunnane, S.C.; Masse, B.; Lemay, A.; Jacques, H.; Asselin, G.; Tremblay-Mercier, J.; Marc, I.; Lamarche, B.; Legare, F. et al. Flaxseed on cardiovascular disease markers in healthy menopausal women: A randomized, double-blind, placebo-controlled trial. Nutrition 2008, 24, 23-30.
18. Faintuch, J.; Horie, L.M.; Barbeiro, H.V.; Barbeiro, D.F.; Soriano, F.G.; Ishida, R.K.; Cecconello, I. Systemic inflammation in morbidly obese subjects: Response to oral supplementation with alpha-linolenic acid. Obes. Surg. 2007, 17, 341-347.
19. Faintuch, J.; Bortolotto, L.A.; Marques, P.C.; Faintuch, J.J.; Franca, J.I.; Cecconello, I. Systemic inflammation and carotid diameter in obese patients: Pilot comparative study with flaxseed powder and cassava powder. Nutr. Hosp. 2011, 26, 208-213.
20. Foster, M.; Petocz, P.; Samman, S. Inflammation markers predict zinc transporter gene expression in women with type 2 diabetes mellitus. J. Nutr. Biochem. 2013, 24, 1655-1661.
21. Hallund, J.; Tetens, I.; Bugel, S.; Tholstrup, T.; Bruun, J.M. The effect of a lignan complex isolated from flaxseed on inflammation markers in healthy postmenopausal women. Nutr. Metab. Cardiovasc. Dis. 2008, 18, 497-502.
22. Hutchins, A.M.; Brown, B.D.; Cunnane, S.C.; Domitrovich, S.G.; Adams, E.R.; Bobowiec, C.E. Daily flaxseed consumption improves glycemic control in obese men and women with pre-diabetes: A randomized study. Nutr. Res. 2013, 33, 367-375.
23. Kaul, N.; Kreml, R.; Austria, J.A.; Richard, M.N.; Edel, A.L.; Dibrov, E.; Hirono, S.; Zettler, M.E.; Pierce, G.N. A comparison of fish oil, flaxseed oil and hempseed oil supplementation on selected parameters of cardiovascular health in healthy volunteers. J. Am. Coll. Nutr. 2008, 27, 51-58.
24. Khalatbari, S.S.; Jamaluddin, R.; Tabibi, H.; Mohd Yusof, B.N.; Atabak, S.; Loh, S.P.; Rahmani, L. Effects of flaxseed consumption on systemic inflammation and serum lipid profile in hemodialysis patients with lipid abnormalities. Hemodial. Int. 2013, 17, 275-281.
25. Kontogianni, M.D.; Vlassopoulos, A.; Gatzieva, A.; Farmaki, A.E.; Katsiougiannis, S.; Panagiotakos, D.B.; Kalogeropoulos, N.; Skopouli, F.N. Flaxseed oil does not affect inflammatorymarkers and lipid profile compared to olive oil, in young, healthy, normal weight adults.Metab. Clin. Exp. 2013, 62, 686-693.
26. Lemos, J.R.; Alencastro, M.G.; Konrath, A.V.; Cargnin, M.; Manfro, R.C. Flaxseed oil supplementation decreases c-reactive protein levels in chronic hemodialysis patients. Nutr. Res. 2012, 32, 921-927.
27. Nelson, T.L.; Stevens, J.R.; Hickey, M.S. Inflammatory markers are not altered by an eight week dietary alpha-linolenic acid intervention in healthy abdominally obese adult males and females. Cytokine 2007, 38, 101-106.
28. Nordstrom, D.C.; Honkanen, V.E.; Nasu, Y.; Antila, E.; Friman, C.; Konttinen, Y.T. Alpha-linolenic acid in the treatment of rheumatoid arthritis. A double-blind, placebo-controlled and randomized study: Flaxseed vs. Safflower seed. Rheumatol. Int. 1995, 14, 231-234.
29. Pan, A.; Demark-Wahnefried, W.; Ye, X.; Yu, Z.; Li, H.; Qi, Q.; Sun, J.; Chen, Y.; Chen, X.; Liu, Y. et al. Effects of a flaxseed-derived lignan supplement on c-reactive protein, il-6 and retinol-binding protein 4 in type 2 diabetic patients. Br. J. Nutr. 2009, 101, 1145-1149.
30. Rallidis, L.S.; Paschos, G.; Liakos, G.K.; Velissaridou, A.H.; Anastasiadis, G.; Zampelas, A. Dietary alpha-linolenic acid decreases c-reactive protein, serum amyloid a and interleukin-6 in dyslipidaemic patients. Atherosclerosis 2003, 167, 237-242.
31. Rhee, Y.; Brunt, A. Flaxseed supplementation improved insulin resistance in obese glucose intolerant people: A randomized crossover design. Nutr. J. 2011, 10, 44.
32. Vargas, M.L.; Almario, R.U.; Buchan, W.; Kim, K.; Karakas, S.E. Metabolic and endocrine effects of long-chain versus essential omega-3 polyunsaturated fatty acids in polycystic ovary syndrome. Metabolism 2011, 60, 1711-1718.
33. Zong, G.; Demark-Wahnefried, W.; Wu, H.; Lin, X. Effects of flaxseed supplementation on erythrocyte fatty acids and multiple cardiometabolic biomarkers among chinese with risk factors of metabolic syndrome. Eur. J. Nutr. 2013, 52, 1547-1551.
34. International Prospective Register of Systemic Reviews. http://www.crd.york.ac.uk/prospero (accessed on 4 November 2015).
35. Adolphe, J.L.; Whiting, S.J.; Juurlink, B.H.; Thorpe, L.U.; Alcorn, J. Health effects with consumption of the flax lignan secoisolariciresinol diglucoside. Br. J. Nutr. 2010, 103, 929-938.
36. Rodriguez-Leyva, D.; Dupasquier, C.M.; McCullough, R.; Pierce, G.N. The cardiovascular effects of flaxseed and its omega-3 fatty acid, alpha-linolenic acid. Can. J. Cardiol. 2010, 26, 489-496.
37. Prasad, K. Flaxseed and cardiovascular health. J. Cardiovasc. Pharmacol. 2009, 54, 369-377.
38. Peterson, J.; Dwyer, J.; Adlercreutz, H.; Scalbert, A.; Jacques, P.; McCullough, M.L. Dietary lignans: Physiology and potential for cardiovascular disease risk reduction. Nutr. Rev. 2010, 68, 571-603.
39. Bloedon, L.T.; Szapary, P.O. Flaxseed and cardiovascular risk. Nutr. Rev. 2004, 62, 18-27.
40. Jadad, A.R.; Moore, R.A.; Carroll, D.; Jenkinson, C.; Reynolds, D.J.; Gavaghan, D.J.; McQuay, H.J. Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control. Clin. Trials 1996, 17, 1-12.
41. Follmann, D.; Elliott, P.; Suh, I.; Cutler, J. Variance imputation for overviews of clinical trials with continuous response. J. Clin. Epidemiol. 1992, 45, 769-773.
42. Choi, J.; Joseph, L.; Pilote, L. Obesity and c-reactive protein in various populations: A systematic review and meta-analysis. Obes. Rev. 2013, 14, 232-244.
43. Singh, T.; Newman, A.B. Inflammatory markers in population studies of aging. Ageing Res. Rev. 2011, 10, 319-329.
44. Dewell, A.; Marvasti, F.F.; Harris, W.S.; Tsao, P.; Gardner, C.D. Low-and high-dose plant and marine (n-3) fatty acids do not affect plasma inflammatory markers in adults with metabolic syndrome. J. Nutr. 2011, 141, 2166-2171.
45. Pearson, T.A.; Mensah, G.A.; Alexander, R.W.; Anderson, J.L.; Cannon, R.O., 3rd; Criqui, M.; Fadl, Y.Y.; Fortmann, S.P.; Hong, Y.; Myers, G.L. et al. Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the centers for disease control and prevention and the american heart association. Circulation 2003, 107, 499-511.
46. Schwab, U.; Lauritzen, L.; Tholstrup, T.; Haldorssoni, T.; Riserus, U.; Uusitupa, M.; Becker, W. Effect of the amount and type of dietary fat on cardiometabolic risk factors and risk of developing type 2 diabetes, cardiovascular diseases, and cancer: A systematic review. Food Nutr. Res. 2014, 58.
47. Li, K.; Huang, T.; Zheng, J.; Wu, K.; Li, D. Effect of marine-derived n-3 polyunsaturated fatty acids on c-reactive protein, interleukin 6 and tumor necrosis factor alpha: A meta-analysis. PLoS ONE 2014, 9, e88103.
48. Taylor, C.G.; Noto, A.D.; Stringer, D.M.; Froese, S.; Malcolmson, L. Dietarymilled flaxseed and flaxseed oil improve n-3 fatty acid status and do not affect glycemic control in individuals with well-controlled type 2 diabetes. J. Am. Coll. Nutr. 2010, 29, 72-80.
49. Plourde, M.; Cunnane, S.C. Extremely limited synthesis of long chain polyunsaturates in adults: Implications for their dietary essentiality and use as supplements. Appl. Physiol. Nutr. Metab. 2007, 32, 619-634.
50. Haidari, F.; Mohammadshahi, M.; Borsi, S.H.; Haghighizadeh, M.H.; Malgard, S. Comparison of essential fatty acid intakes and serum levels of inflammatory factors between asthmatic and healthy adults: A case-control study. Iran. J. Allergy Asthma Immunol. 2014, 13, 335-342.
51. Bjermo, H.; Iggman, D.; Kullberg, J.; Dahlman, I.; Johansson, L.; Persson, L.; Berglund, J.; Pulkki, K.; Basu, S.; Uusitupa, M. et al. Effects of n-6 pufas compared with sfas on liver fat, lipoproteins, and inflammation in abdominal obesity: A randomized controlled trial. Am. J. Clin. Nutr. 2012, 95, 1003-1012.
52. Al-Lahham, S.H.; Peppelenbosch, M.P.; Roelofsen, H.; Vonk, R.J.; Venema, K. Biological effects of propionic acid in humans; metabolism, potential applications and underlying mechanisms. Biochim. Biophys. Acta 2010, 1801, 1175-1183.
53. Jiao, J.; Xu, J.Y.; Zhang, W.; Han, S.; Qin, L.Q. Effect of dietary fiber on circulating c-reactive protein in overweight and obese adults: A meta-analysis of randomized controlled trials. Int. J. Food Sci. Nutr. 2015, 66, 114-119.
54. Scott, K.P.; Antoine, J.M.; Midtvedt, T.; van Hemert, S. Manipulating the gut microbiota to maintain health and treat disease. Microb. Ecol. Health Dis. 2015, 26, 25877.
55. Visser, M.; Bouter, L.M.; McQuillan, G.M.; Wener, M.H.; Harris, T.B. Elevated c-reactive protein levels in overweight and obese adults. JAMA 1999, 282, 2131-2135.
56. Ursoniu, S.; Sahebkar, A.; Andrica, F.; Serban, C.; Banach, M. Effects of flaxseed supplements on blood pressure: A systematic review and meta-analysis of controlled clinical trial. Clin. Nutr. 2015.
57. Gould, A.L.; Davies, G.M.; Alemao, E.; Yin, D.D.; Cook, J.R. Cholesterol reduction yields clinical benefits: Meta-analysis including recent trials. Clin. Ther. 2007, 29, 778-794.
58. Sahebkar, A.; Serban, C.; Ursoniu, S.; Banach, M. Effect of garlic on plasma lipoprotein(a) concentrations: A systematic review and meta-analysis of randomized controlled clinical trials. Nutrition 2016, 32, 33-40.
59. Serban, C.; Sahebkar, A.; Antal, D.; Ursoniu, S.; Banach, M. Effects of supplementation with green tea catechins on plasma C-reactive protein concentrations: A systematic review and meta-analysis of randomized controlled trials. Nutrition 2015, 31, 1061-1071.
60. Ursoniu, S.; Sahebkar, A.; Serban, M.C.; Banach, M. Lipid profile and glucose changes after supplementation with astaxanthin: A systematic review and meta-analysis of randomized controlled trials. Arch. Med. Sci. 2015, 11, 253-266.
61. Banach, M.; Rizzo, M.; Toth, P.P.; Farnier, M.; Davidson, M.H.; Al-Rasadi, K.; Aronow, W.S.; Athyros, V.; Djuric, D.M.; Ezhov, M.V. et al. Statin intolerance-An attempt at a unified definition. Position paper from an International Lipid Expert Panel. Arch. Med. Sci. 2015, 11, 1-23.